Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

计划入组 168 人 · 首次发布于 2023 年 5 月 6 日

Ruxolitinib in Estrogen Receptor Positive Breast Cancer

计划入组 25 人 · 首次发布于 2012 年 5 月 9 日

Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts

计划入组 10 人 · 首次发布于 2016 年 4 月 27 日

selective estrogen receptor degraders

dual estrogen receptor-alpha/NF-kappa-B inhibitors (breast cancer)

Breast cancer (BreakBio)

Arvinas Estrogen Receptor, Inc.

United States

JAPAN BREAST CANCER RESEARCH GROUP

Japan

ANZ BREAST CANCER TRIALS GROUP LIMITED

Australia

Iovance Biotherapeutics Receives FDA Clearance for Next-Generation IL-12 Tethered TIL Therapy Trial

Breakthrough Strategy Overcomes Immunotherapy Resistance in Estrogen Receptor-Positive Breast Cancer

Imlunestrant Shows Promise in ER-Positive, HER2-Negative Advanced Breast Cancer